SLP

Simulations Plus, Inc. (NASDAQ:SLP) is a specialized software and services company founded in 1996 and headquartered in Lancaster, California. The company went public in 1997 and has evolved into a leading provider of drug discovery and development software that utilizes artificial intelligence and machine learning technologies. Through strategic acquisitions over the years, including Cognigen, DILIsym, Lixoft, Immunetrics, and most recently Pro-ficiency, Simulations Plus has expanded its capabilities across the entire drug development continuum, serving pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies worldwide, as well as academic institutions and regulatory agencies.